Panel discussion on new technologies in lymphoma - the applications of circulating tumor DNA
Ash Alizadeh et al.
How next-generation sequencing will change the treatment of multiple myeloma
Ibrutinib updates from ASH 2016
Only the beginning of precision medicine and multiple myeloma.
Identifying predictive markers for CLL